Aromatic ring-condensed heterocyclic compounds as potassium channel regulators, and their production and use

A novel aromatic ring-condensed heterocyclic compound addresses the selectivity and safety issues of existing potassium channel regulators by providing enhanced potassium channel opening activity and reduced adverse effects, effectively treating conditions like epilepsy and anxiety disorders.

JP7833217B2Active Publication Date: 2026-03-19SHANGHAI ZHIMENG BIOPHARMA CO LTD
6 Cites 0 Cited by

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Filing Date
2023-01-19
Publication Date
2026-03-19

Smart Images

  • Figure 0007833217000001
    Figure 0007833217000001
  • Figure 0007833217000002
    Figure 0007833217000002
  • Figure 0007833217000003
    Figure 0007833217000003
Patent Text Reader

Abstract

The present invention relates to aromatic fused heterocyclic compounds as potassium channel regulators and their preparation and use.Specifically, the compounds of the present invention have the structure represented by Formula I, in which the definitions of each group and substituent are as described in the specification.The present invention also discloses a method for preparing the compounds and their use as potassium channel regulators. [Formula 1] JPEG2025504539000029.jpg57132
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Benzoheterocyclic derivatives

    CN103508960A

  • Heterocyclic amide, manufacture and medicinal composition having leukotriene antagonistic activity

    JP1986178963A

  • Novel amide derivative, manufacture and leucotriene antagonist

    JP1987093274A

  • JPP7458670B

  • Substituted arylamino -1,2,3,4-tetrahydro naphthalenes and -2,3-dihydro-1H-indenes as potassium channel modulators

    US20080146661A1